Abstract
Vascular calcification (VC) is characterized by pathological depositions of calcium and phosphate in the arteries and veins via an active cell-regulated process, in which vascular smooth muscle cells (VSMCs) transform into osteoblast/chondrocyte-like cells as in bone formation. VC is associated with significant morbidity and mortality in chronic kidney disease (CKD) and cardiovascular disease, but the underlying mechanisms remain unclear. In this study we investigated the role of large-conductance calcium-activated potassium (BK) channels in 3 experimental VC models. VC was induced in vascular smooth muscle cells (VSMCs) by β-glycerophosphate (β-GP), or in rats by subtotal nephrectomy, or in mice by high-dosage vitamin D3. We showed that the expression of BK channels in the artery of CKD rats with VC and in β-GP-treated VSMCs was significantly decreased, which was functionally confirmed by patch-clamp recording. In β-GP-treated VSMCs, BK channel opener NS1619 (20 μM) significantly alleviated VC by decreasing calcium content and alkaline phosphatase activity. Furthermore, NS1619 decreased mRNA expression of ostoegenic genes OCN and OPN, as well as Runx2 (a key transcription factor involved in preosteoblast to osteoblast differentiation), and increased the expression of α-SMA protein, whereas BK channel inhibitor paxilline (10 μM) caused the opposite effects. In primary cultured VSMCs from BK−/− mice, BK deficiency aggravated calcification as did BK channel inhibitor in normal VSMCs. Moreover, calcification was more severe in thoracic aorta rings of BK−/− mice than in those of wild-type littermates. Administration of BK channel activator BMS191011 (10 mg· kg−1 ·d−1) in high-dosage vitamin D3-treated mice significantly ameliorated calcification. Finally, co-treatment with Akt inhibitor MK2206 (1 μM) or FoxO1 inhibitor AS1842856 (3 μM) in calcified VSMCs abrogated the effects of BK channel opener NS1619. Taken together, activation of BK channels ameliorates VC via Akt/FoxO1 signaling pathways. Strategies to activate BK channels and/or enhance BK channel expression may offer therapeutic avenues to control VC.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Peeters MJ, van den Brand JA, van Zuilen AD, Koster Y, Bots ML, Vervloet MG, et al. Abdominal aortic calcification in patients with CKD. J Nephrol. 2017;30:109–18.
Byon CH, Chen Y. Molecular mechanisms of vascular calcification in chronic kidney disease: the link between bone and the vasculature. Curr Osteoporos Rep. 2015;13:206–15.
Disthabanchong S. Vascular calcification in chronic kidney disease: pathogenesis and clinical implication. World J Nephrol. 2012;1:43–53.
Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol. 2009;20:1453–64.
Vervloet M, Cozzolino M. Vascular calcification in chronic kidney disease: different bricks in the wall? Kidney Int. 2017;91:808–17.
Voelkl J, Cejka D, Alesutan I. An overview of the mechanisms in vascular calcification during chronic kidney disease. Curr Opin Nephrol Hypertens. 2019;28:289–96.
Shroff RC, Shanahan CM. The vascular biology of calcification. Semin Dial. 2007;20:103–9.
Latorre R, Castillo K, Carrasquel-Ursulaez W, Sepulveda RV, Gonzalez-Nilo F, Gonzalez C, et al. Molecular determinants of BK channel functional diversity and functioning. Physiol Rev. 2017;97:39–87.
Dopico AM, Bukiya AN, Jaggar JH. Calcium- and voltage-gated BK channels in vascular smooth muscle. Pflug Arch. 2018;470:1271–89.
Jia X, Yang J, Song W, Li P, Wang X, Guan C, et al. Involvement of large conductance Ca2+-activated K+ channel in laminar shear stress-induced inhibition of vascular smooth muscle cell proliferation. Pflug Arch. 2013;465:221–32.
Rusch NJ. BK channels in cardiovascular disease: a complex story of channel dysregulation. Am J Physiol Heart Circ Physiol. 2009;297:H1580–2.
Zhu Y, Ye P, Chen SL, Zhang DM. Functional regulation of large conductance Ca2+-activated K+ channels in vascular diseases. Metabolism. 2018;83:75–80.
Lu T, Chai Q, Jiao G, Wang XL, Sun X, Furuseth JD, et al. Downregulation of BK channel function and protein expression in coronary arteriolar smooth muscle cells of type 2 diabetic patients. Cardiovasc Res. 2019;115:145–53.
Borbouse L, Dick GM, Asano S, Bender SB, Dincer UD, Payne GA, et al. Impaired function of coronary BK(Ca) channels in metabolic syndrome. Am J Physiol Heart Circ Physiol. 2009;297:H1629–37.
Freise C, Querfeld U. Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34. Pharmacol Res. 2014;85:6–14.
Hei H, Gao J, Dong J, Tao J, Tian L, Pan W, et al. BK knockout by TALEN-mediated gene targeting in osteoblasts: KCNMA1 determines the proliferation and differentiation of osteoblasts. Mol Cells. 2016;39:530–5.
Wang Y, Guo Q, Hei H, Tao J, Zhou Y, Dong J, et al. BK ablation attenuates osteoblast bone formation via integrin pathway. Cell Death Dis. 2019;10:738.
Alesutan I, Feger M, Tuffaha R, Castor T, Musculus K, Buehling SS, et al. Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine. Cardiovasc Res. 2016;110:408–18.
Kwon DH, Eom GH, Ko JH, Shin S, Joung H, Choe N, et al. MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification. Nat Commun. 2016;7:10492.
Song Y, Hou M, Li Z, Luo C, Ou JS, Yu H, et al. TLR4/NF-κB/Ceramide signaling contributes to Ox-LDL-induced calcification of human vascular smooth muscle cells. Eur J Pharmacol. 2017;794:45–51.
Lee K, Kim H, Park HS, Kim KJ, Song H, Shin HI, et al. Targeting of the osteoclastogenic RANKL-RANK axis prevents osteoporotic bone loss and soft tissue calcification in coxsackievirus B3-infected mice. J Immunol. 2013;190:1623–30.
Wang Y, Tao J, Wang M, Yang L, Ning F, Xin H, et al. Mechanism of regulation of big-conductance Ca2+-activated K+ channels by mTOR complex 2 in podocytes. Front Physiol. 2019;10:167.
Zebger-Gong H, Müller D, Diercke M, Haffner D, Hocher B, Verberckmoes S, et al. 1,25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: up-regulation of osteoblast markers, calcium-transporting proteins and osterix. J Hypertens. 2011;29:339–48.
Zhang S, Zhang Z, Shen Y, Zhu Y, Du K, Guo J, et al. SCN9A epileptic encephalopathy mutations display a gain-of-function phenotype and distinct sensitivity to oxcarbazepine. Neurosci Bull. 2020;36:11–24.
Chen Q, Tao J, Hei H, Li F, Wang Y, Peng W, et al. Up-regulatory effects of curcumin on large conductance Ca2+-activated K+ channels. PLoS One. 2015;10:e0144800.
Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar VM, et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem. 2008;283:15319–27.
Voelkl J, Luong TT, Tuffaha R, Musculus K, Auer T, Lian X, et al. SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling. J Clin Invest. 2018;128:3024–40.
Knaus HG, McManus OB, Lee SH, Schmalhofer WA, Garcia-Calvo M, Helms LM, et al. Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry. 1994;33:5819–28.
Choi TY, Lee SH, Kim SJ, Jo Y, Park CS, Choi SY. BK channel blocker paxilline attenuates thalidomide-caused synaptic and cognitive dysfunctions in mice. Sci Rep. 2018;8:17653.
Ha CM, Park S, Choi YK, Jeong JY, Oh CJ, Bae KH, et al. Activation of Nrf2 by dimethyl fumarate improves vascular calcification. Vascul Pharmacol. 2014;63:29–36.
Price PA, Faus SA, Williamson MK. Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol. 2000;20:317–27.
Romine JL, Martin SW, Meanwell NA, Gribkoff VK, Boissard CG, Dworetzky SI, et al. 3-[(5-Chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2(3H)-one, BMS-191011: opener of large-conductance Ca2+-activated potassium (maxi-K) channels, identification, solubility, and SAR. J Med Chem. 2007;50:528–42.
Xiang RF, Wang Y, Zhang N, Xu WB, Cao Y, Tong J, et al. MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway. Cell Death Dis. 2017;8:e2776.
Biggs WH 3rd, Meisenhelder J, Hunter T, Cavenee WK, Arden KC. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA. 1999;96:7421–6.
Yu F, Wei R, Yang J, Liu J, Yang K, Wang H, et al. FoxO1 inhibition promotes differentiation of human embryonic stem cells into insulin producing cells. Exp Cell Res. 2018;362:227–34.
Aihara Y, Jahromi BS, Yassari R, Nikitina E, Agbaje-Williams M, Macdonald RL. Molecular profile of vascular ion channels after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004;24:75–83.
Pabbidi MR, Roman RJ. Elevated K+ channel activity opposes vasoconstrictor response to serotonin in cerebral arteries of the Fawn Hooded Hypertensive rat. Physiol Genomics. 2017;49:27–36.
Kim N, Chung J, Kim E, Han J. Changes in the Ca2+-activated K+ channels of the coronary artery during left ventricular hypertrophy. Circ Res. 2003;93:541–7.
Paloian NJ, Giachelli CM. A current understanding of vascular calcification in CKD. Am J Physiol Ren Physiol. 2014;307:F891–900.
Kaartinen MT, Murshed M, Karsenty G, McKee MD. Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice. J Histochem Cytochem. 2007;55:375–86.
Ren J, Cheng Y, Wen X, Liu P, Zhao F, Xin F, et al. BK(Ca) channel participates in insulin-induced lipid deposition in adipocytes by increasing intracellular calcium. J Cell Physiol. 2021;236:5818–31.
Bentzen BH, Osadchii O, Jespersen T, Hansen RS, Olesen SP, Grunnet M. Activation of big conductance Ca2+-activated K+ channels (BK) protects the heart against ischemia-reperfusion injury. Pflug Arch. 2009;457:979–88.
Wang Y, Ali Y, Lim CY, Hong W, Pang ZP, Han W. Insulin-stimulated leptin secretion requires calcium and PI3K/Akt activation. Biochem J. 2014;458:491–8.
Lu T, Chai Q, Yu L, d’Uscio LV, Katusic ZS, He T, et al. Reactive oxygen species signaling facilitates FOXO-3a/FBXO-dependent vascular BK channel β1 subunit degradation in diabetic mice. Diabetes. 2012;61:1860–8.
Deng L, Huang L, Sun Y, Heath JM, Wu H, Chen Y. Inhibition of FOXO1/3 promotes vascular calcification. Arterioscler Thromb Vasc Biol. 2015;35:175–83.
Acknowledgements
This work was supported by grants from the National Natural Science Foundation of China (No. 81773801 and No. 81973385 to XMZ; No. 82074162 to JT); Shanghai Science and Technology Innovation (No. 20410713300 to XMZ); and the Experimental Animal Project of Shanghai Science and Technology Commission (No. 201409004700).
Author information
Authors and Affiliations
Contributions
XMZ and HX designed the study; FLN, JT, DDL, LLT, and MLW performed the experiments; FLN, JT, and LLT performed data analysis; FLN and JT wrote the manuscript. SR, CL, and HC revised the manuscript. All authors read and approved the submitted version of the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Ning, Fl., Tao, J., Li, Dd. et al. Activating BK channels ameliorates vascular smooth muscle calcification through Akt signaling. Acta Pharmacol Sin 43, 624–633 (2022). https://doi.org/10.1038/s41401-021-00704-6
Received:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41401-021-00704-6
Keywords
This article is cited by
-
Osteocalcin deficiency attenuates neointima formation after vascular injury in rat
BMC Cardiovascular Disorders (2025)
-
Multiomic analysis of different horse breeds reveals that gut microbial butyrate enhances racehorse athletic performance
npj Biofilms and Microbiomes (2025)
